What is Saba Zabetian's NPI number?

Saba Zabetian's National Provider Identifier (NPI) is 1750648366, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Saba Zabetian's specialty?

Saba Zabetian is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Saba Zabetian located?

Saba Zabetian's practice location on file with NPPES is 940 W University Ave Ste 101, Georgetown, TX 78626-5430.

What is Saba Zabetian's phone number?

The practice phone number listed in the NPPES registry for Saba Zabetian is (512) 819-0264.

Does Saba Zabetian accept Medicare?

Saba Zabetian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Saba Zabetian's NPI active?

Yes — Saba Zabetian's NPI (1750648366) is active in the NPPES registry as of the last update on 2024-08-05.

IndividualActiveAccepts Medicare

Saba Zabetian, MD

NPI 1750648366 · Dermatology Physician · Georgetown, TX

Saba Zabetian, MD is a Dermatology Physician provider in Georgetown, TX (NPI 1750648366).

Provider details

NPI number: 1750648366
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 13856 (ND)

Practice location

940 W University Ave Ste 101

Georgetown, TX 78626-5430

Phone: (512) 819-0264

Fax: (512) 406-6242

Street-level locationGet directions

More TX providers

Mailing address

6210 E Hwy 290

Austin, TX 78723-1142

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense T2796 (TX)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense 13856 (ND)
Allopathic & Osteopathic Physicians
Student in an Organized Health Care Education/Training Program390200000X
Student, Health Care

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(83/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure33% of score
14 yrs in NPPES registry
Profile completeness33% of score
100% of core fields populated
Practice footprint20% of score
1 documented practice location
Open Payments transparency13% of score
Has Open Payments disclosures (2024)

Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	379	$3
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	98	$96
Destruction of Precancer Skin Growth, 1 Growth17000	93	$47
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	90	$66
Biopsy of Related Skin Growth, First Growth11102	68	$46
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	118	39
Hydrocortisone	62	35
Triamcinolone Acetonide	45	32
Clobetasol Propionate	42	21
Ammonium Lactate	40	16
Clindamycin Phosphate	21	—
Fluocinonide	20	14
Fluocinolone Acetonide	16	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$14 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2012-04-19
Last updated: 2024-08-05
Certified: 2024-08-05

Frequently asked questions

What is Saba Zabetian's NPI number?: Saba Zabetian's National Provider Identifier (NPI) is 1750648366, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Saba Zabetian's specialty?: Saba Zabetian is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Saba Zabetian located?: Saba Zabetian's practice location on file with NPPES is 940 W University Ave Ste 101, Georgetown, TX 78626-5430.
What is Saba Zabetian's phone number?: The practice phone number listed in the NPPES registry for Saba Zabetian is (512) 819-0264.
Does Saba Zabetian accept Medicare?: Saba Zabetian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Saba Zabetian's NPI active?: Yes — Saba Zabetian's NPI (1750648366) is active in the NPPES registry as of the last update on 2024-08-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	379	$3
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	98	$96
Destruction of Precancer Skin Growth, 1 Growth17000	93	$47
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	90	$66
Biopsy of Related Skin Growth, First Growth11102	68	$46
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

118

Hydrocortisone

Triamcinolone Acetonide

Clobetasol Propionate

Ammonium Lactate

Clindamycin Phosphate

—

Fluocinonide

Fluocinolone Acetonide

—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$14 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments